Palo Atlo, CA 10/14/08—Varian has announced that it expects its sales for the fiscal year ended October 3 to exceed $1 billion. The company forecasts non-GAAP adjusted diluted EPS of more than $2.80, compared to previous guidance of $2.74 plus or minus $0.05. GAAP diluted EPS is expected to exceed $2.11, compared to the previous […]
Venlo, the Netherlands 10/1/08; Uppsala, Sweden 10/1/08—QIAGEN NV has acquired the assets of the Biosystems business and the remaining 17.5% of Corbett Life Science (see IBO 7/15/08) from Biotage AB for approximately $53 million in cash and performance milestone payments of up to $7 million over four years. The Biosystems business develops and sells the […]
Second-quarter revenues for IBO’s Lab Equipment/Consumables Sales Index grew 12.8% to $912.0 million, and operating profits jumped 18.7% to $273.5 million. Adjusted operating margins improved 150 basis points to 30.0% of sales. Biohit Oy’s second-quarter sales grew 14% to €9.1 million ($14.2 million = €0.64 = $1) from €7.9 million ($10.7 million = €0.74 = […]
Due to the upcoming presidential elections, the US Congress essentially has put the fiscal year 2009 budget, which started October 1, 2008, on hold. A continuing resolution was passed to fund the federal agencies that did not receive final budget appropriations through March 6, 2009. Among the agencies operating under the continuing resolution are three […]
Hollywood, FL 10/6/08—STARLIMS Technologies, a provider of laboratory information management systems (LIMS), has announced that it expects third-quarter revenues of $5 million and GAAP EPS of $(0.03)–$0.01. This compares to third-quarter 2007 sales of $6.2 million and GAAP EPS of $0.18. “Our business in the third quarter was impacted by increased tightening of IT budgets […]
On Monday, September 29, the US House of Representatives rejected the $700 billion bailout package, sending the Dow Jones Industrial Average, S&P 500 and NASDAQ down 7.0%, 8.8% and 9.1%, respectively. It was the largest single-day point decline for the Dow Jones in its history. The plan, which would provide immediate short-term credit relief, was […]
San Diego, CA 9/23/08—Sequenom has agreed to acquire the Center for Molecular Medicine (CMM), a Clinical Laboratory Improvement Act–approved molecular pathology lab, for approximately $4.0 million, less CMM’s cash at closing. Ninety percent of the purchase price will be paid in stock. Based in Grand Rapids, Michigan, CMM is a joint venture of nonprofit health […]
New York, NY 9/22/08; South San Francisco, 9/26/08—Citing market instability, Fluidigm has withdrawn its registration statement for an IPO. Fluidigm, which develops microfluidic systems for drug development (see IBO 4/30/08), had originally planned to begin trading on September 19, but postponed the offering several times. Fluidigm had planned to raise $79.5 million in an offering […]
In the second quarter of 2008, revenues for IBO’s Life Science Sales Index grew 11.0% to $2,358 million, while operating profit jumped 26.9% to $382 million and operating margin climbed 200 basis points to 16.2% of sales. Second-quarter sales for Beckman Coulter’s Life Science segment grew 9.3%, or 4.3% in constant currency, to $127.5 million […]
Total US R&D expenditures increased an estimated 5.8% in 2007, or 3.1% when adjusted to 2000 dollars to exclude inflation, to $368,098 million, according to the latest data from the National Science Foundation (NSF). Industry was the primary source of the increase, continuing a trend evident since the 1980s that also reflects slower increases in […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
